213,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 2-4 Wochen
payback
107 °P sammeln
  • Gebundenes Buch

This edition has been completely revised and represents the research, practice, and policy in substance use disorder (SUD) treatment. A one-stop reference for evidence-based information on neurobiology, assessment, treatment, and research trends in SUDs, the book is an indispensable resource for trainees and veteran clinicians alike.

Produktbeschreibung
This edition has been completely revised and represents the research, practice, and policy in substance use disorder (SUD) treatment. A one-stop reference for evidence-based information on neurobiology, assessment, treatment, and research trends in SUDs, the book is an indispensable resource for trainees and veteran clinicians alike.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Kathleen T. Brady, M.D., Ph.D., is Distinguished University Professor and Vice President for Research in the Department of Psychiatry and Behavioral Sciences, Clinical Neuroscience Division, as well as Director of the South Carolina Clinical and Translational Research Institute, at the Medical University of South Carolina, in Charleston, South Carolina. Frances R. Levin, M.D., is Kennedy-Leavy Professor of Psychiatry at Columbia University Medical Center, and Chief of the Division on Substance Use Disorders at the New York State Psychiatric Institute in New York, New York. Marc Galanter, M.D., is Professor of Psychiatry and Director of the Division of Alcoholism and Drug Abuse at New York University School of Medicine in New York, New York. Herbert D. Kleber, M.D., was Professor of Psychiatry and Director of the Division on Substance Abuse at Columbia University in New York, New York.